Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2017 12:53 ET | Source: CohBar, Inc.

CohBar Announces Approval for Listing on the NASDAQ Capital Market

NASDAQ Trading to Begin on December 15, 2017 Under Existing Ticker Symbol CWBR MENLO PARK, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative...
December 07, 2017 09:00 ET | Source: CohBar, Inc.

CohBar Announces the Appointment of Dr. John Amatruda to its Board

MENLO PARK, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to...
November 13, 2017 16:03 ET | Source: CohBar, Inc.

CohBar, Inc. Announces Third Quarter 2017 Financial Results

MENLO PARK, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), an innovative biotechnology company focused on developing mitochondria based...
October 26, 2017 09:00 ET | Source: CohBar, Inc.

CohBar, Inc. to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

MENLO PARK, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to...
October 23, 2017 09:00 ET | Source: CohBar, Inc.

CohBar Presents Preclinical Data on CB4209/CB4211 Program for NASH at the AASLD Liver Meeting® 2017

MENLO PARK, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to...
October 04, 2017 09:00 ET | Source: CohBar, Inc.

CohBar, Inc. Announces Scientific Presentation of CB4209/CB4211 Program for NASH at The AASLD Liver Meeting® 2017

MENLO PARK, Calif., Oct. 04, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) and (TSXV:COB.U) (“CohBar” or the “Company”) today announced that it will present preclinical data on CB4209/CB4211,...
September 08, 2017 09:00 ET | Source: CohBar, Inc.

CohBar to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York on September 12, 2017

MENLO PARK, Calif., Sept. 08, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to...
August 14, 2017 16:05 ET | Source: CohBar, Inc.

CohBar, Inc. Announces Second Quarter 2017 Financial Results

MENLO PARK, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), an innovative biotechnology company focused on developing mitochondria based...
July 27, 2017 09:00 ET | Source: CohBar, Inc.

CohBar, Inc. to Announce Second Quarter 2017 Financial Results and Host Conference Call for Shareholders on August 14, 2017

MENLO PARK, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSX-V:COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs)...
July 17, 2017 09:00 ET | Source: CohBar, Inc.

CohBar, Inc. Completes US$5.2 Million Private Placement

MENLO PARK, Calif., July 17, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company focused on developing mitochondria...